» Articles » PMID: 25951871

Individualized Medicine Enabled by Genomics in Saudi Arabia

Overview
Publisher Biomed Central
Specialty Genetics
Date 2015 May 9
PMID 25951871
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The biomedical research sector in Saudi Arabia has recently received special attention from the government, which is currently supporting research aimed at improving the understanding and treatment of common diseases afflicting Saudi Arabian society. To build capacity for research and training, a number of centres of excellence were established in different areas of the country. Among these, is the Centre of Excellence in Genomic Medicine Research (CEGMR) at King Abdulaziz University, Jeddah, with its internationally ranked and highly productive team performing translational research in the area of individualized medicine. Here, we present a panorama of the recent trends in different areas of biomedical research in Saudi Arabia drawing from our vision of where genomics will have maximal impact in the Kingdom of Saudi Arabia. We describe advances in a number of research areas including; congenital malformations, infertility, consanguinity and pre-implantation genetic diagnosis, cancer and genomic classifications in Saudi Arabia, epigenetic explanations of idiopathic disease, and pharmacogenomics and personalized medicine. We conclude that CEGMR will continue to play a pivotal role in advances in the field of genomics and research in this area is facing a number of challenges including generating high quality control data from Saudi population and policies for using these data need to comply with the international set up.

Citing Articles

The future of personalized medicine in Saudi Arabia: Opportunities and challenges.

Mawkili W Saudi Med J. 2025; 46(1):19-25.

PMID: 39779366 PMC: 11717103. DOI: 10.15537/smj.2025.46.1.20240700.


Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma.

Hanbazazh M, Samman A, Samargandy S, Al-Maghrabi J Libyan J Med. 2023; 18(1):2283953.

PMID: 37988377 PMC: 11018318. DOI: 10.1080/19932820.2023.2283953.


Perceived risks of over-the-counter medication use among pregnant Saudi mothers: A cross-sectional study.

Alosaimi A, Zamzam S, Berdida D, Villagracia H J Taibah Univ Med Sci. 2022; 17(5):755-764.

PMID: 36050964 PMC: 9396048. DOI: 10.1016/j.jtumed.2022.03.001.


Genetic data sharing and artificial intelligence in the era of personalized medicine based on a cross-sectional analysis of the Saudi human genome program.

Alrefaei A, Hawsawi Y, Almaleki D, Alafif T, Alzahrani F, Bakhrebah M Sci Rep. 2022; 12(1):1405.

PMID: 35082362 PMC: 8791994. DOI: 10.1038/s41598-022-05296-7.


Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians.

Albitar L, Alchamat G BMC Health Serv Res. 2021; 21(1):1031.

PMID: 34592972 PMC: 8485485. DOI: 10.1186/s12913-021-07040-9.


References
1.
Boivin J, Bunting L, Collins J, Nygren K . International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007; 22(6):1506-12. DOI: 10.1093/humrep/dem046. View

2.
Ali-Khan S, Daar A, Shuman C, Ray P, Scherer S . Whole genome scanning: resolving clinical diagnosis and management amidst complex data. Pediatr Res. 2009; 66(4):357-63. DOI: 10.1203/PDR.0b013e3181b0cbd8. View

3.
Alhamdan N, Almazrou Y, Alswaidi F, Choudhry A . Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007; 9(6):372-7. DOI: 10.1097/gim.0b013e318065a9e8. View

4.
Dyer S . International estimates on infertility prevalence and treatment seeking: potential need and demand for medical care. Hum Reprod. 2009; 24(9):2379-80. DOI: 10.1093/humrep/dep219. View

5.
Heller T, Kirchheiner J, Armstrong V, Luthe H, Tzvetkov M, Brockmoller J . AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping. Ther Drug Monit. 2006; 28(5):673-7. DOI: 10.1097/01.ftd.0000246764.67129.2a. View